{"id":753,"date":"2024-08-26T21:33:48","date_gmt":"2024-08-26T18:33:48","guid":{"rendered":"https:\/\/patheconomics.com\/?p=753"},"modified":"2025-02-17T22:18:39","modified_gmt":"2025-02-17T19:18:39","slug":"upcoming-ispor-europe-2024-17-20-november","status":"publish","type":"post","link":"https:\/\/patheconomics.com\/ar\/upcoming-ispor-europe-2024-17-20-november\/","title":{"rendered":"Upcoming ISPOR Europe 2024 17-20 November"},"content":{"rendered":"

Event Details:<\/span>\u00a0<\/span><\/p>\n

DATE: November 17, 2024 – November 20, 2024<\/span><\/span><\/p>\n

WEBSITE:\u00a0ISROP EUROE 2024<\/span><\/a><\/span><\/p>\n

LOCATION: Barcelona, Spain<\/span><\/span><\/p>\n

 <\/p>\n\n\n\n
\n

Overview<\/span><\/strong><\/p>\n

ISPOR\u2014The Professional Society for Health Economics and Outcomes Research (HEOR) is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE\u00ae-indexed publications, good practices guidance, education, collaboration, and tools\/resources in the field.<\/span><\/p>\n

ISPOR\u2019s community of 14,000 individual and chapter members representing more than 100 countries engages a wide variety of healthcare stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations. The Society\u2019s leadership has served as an unbiased resource and catalyst for innovation in the field for more than 25 years.<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n
ISPOR\u2019s Global Stakeholders<\/span><\/strong><\/p>\n

ISPOR believes that by including a wide variety of stakeholder viewpoints, the Society can advance the science and increase the understanding and application of health economics and outcomes research (HEOR) methods to improve healthcare decisions. Learn more about our members here<\/a>.<\/span><\/p>\n<\/td>\n

\n

\"\"<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n\n\n\n
Our Contributions:<\/strong><\/span><\/td>\n\u00a0<\/span><\/td>\n\u00a0<\/span><\/strong><\/td>\n<\/tr>\n
– In our collaboration with the Saudi Gastro Association and academic institutions in the kingdom of Saudi Arabia, we evaluated the Budget Impact Analysis of Subcutaneous Infliximab (CT-P13 SC)<\/strong> for Treating Inflammatory Bowel Disease in Saudi Arabia: Analysis from Payer Perspective.<\/span><\/td>\n\u00a0<\/span><\/td>\nPath Economics is attending the ISPOR Europe 2024 to present this abstract on Tuesday, 19 November 2024 10:30 – 13:30.<\/span><\/strong><\/td>\n<\/tr>\n
\u00a0<\/span><\/td>\n\u00a0<\/span><\/td>\n\u00a0<\/span><\/strong><\/td>\n<\/tr>\n
– Jointly with the Algerian Ministry of Health, we conducted a Cost-Effectiveness of Febuxostat 120\/80 mg<\/strong> as a Second-Line after Allopurinol 100\/300mg in Gout Patients in Algeria. <\/span><\/td>\n\u00a0<\/span><\/td>\nPath Economics is attending the ISPOR Europe 2024 to present this abstract on Tuesday, 19 November 2024 16:00 – 19:00.<\/span><\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n

\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Event Details:\u00a0 DATE: November 17, 2024 – November 20, 2024 WEBSITE:\u00a0ISROP EUROE 2024 LOCATION: Barcelona, Spain   Overview ISPOR\u2014The Professional Society for Health Economics and Outcomes Research (HEOR) is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed […]<\/p>\n","protected":false},"author":2,"featured_media":748,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[27,28],"class_list":["post-753","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","tag-isporeurope","tag-patheconomics"],"acf":[],"_links":{"self":[{"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/posts\/753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/comments?post=753"}],"version-history":[{"count":1,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/posts\/753\/revisions"}],"predecessor-version":[{"id":990,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/posts\/753\/revisions\/990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/media\/748"}],"wp:attachment":[{"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/media?parent=753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/categories?post=753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patheconomics.com\/ar\/wp-json\/wp\/v2\/tags?post=753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}